Quote:
Originally Posted by Tupelo3
Georgetown released some new pharmacokinetics and other biomarker data in a new report. Keep in mind it was just signal dose on small sample. I didn’t see anything groundbreaking here.
BPS Publications |
Some more data but what a waste of a study. I can't see how much can be learned from a single dose. No discussion of how this moved any up the road to approval/validation as a useful drug.